Jane Street Group, LLC Alkermes Plc. Call Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $172,575 - $214,125	7,500 New	7,500 $209,000
Q1 2022 May 17, 2022	SELL	$23.07 - $27.99 $1.73 Million - $2.1 Million	-75,200 Reduced 69.05%	33,700 $887,000
Q4 2021 Feb 15, 2022	BUY	$21.47 - $32.08 $1.3 Million - $1.94 Million	60,500 Added 125.0%	108,900 $2.53 Million
Q3 2021 Nov 16, 2021	BUY	$23.37 - $32.13 $595,935 - $819,315	25,500 Added 111.35%	48,400 $1.49 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $430,062 - $575,935	22,900 New	22,900 $562,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.88B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.